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INTRODUCTION
Viral hepatitis is a major public health problem through-
out the world. Although hepatitis A virus (HAV) infection
is a self-limited disease, the infection in adults causes signif-
icant morbidity, resulting in long absences from work for
several weeks, possible hospitalization, and occasional mor-
tality resulting from acute fulminant hepatitis (1, 2). Infec-
tion rates have declined with better hygiene practice and
public sanitation, but remain heterogeneous across geographic
and socioeconomic strata (1, 2).
Hepatitis A has become a major cause of acute viral hepati-
tis in young adults in Korea since 1996 (3-7). Korea seems to
be a country in transition from a high to low endemic region
and faces the paradox of increasing disease burden with decreas-
ing disease incidence. The current national immunization
guide recommends HAV vaccination for individuals at incre-
ased risk of infection or its complications (3, 4). The guide
also states that a universal immunization program should be
considered, but further discussion is needed (3, 4). 
Korea, has a draft system, and the military has been espe-
cially vigilant for viral hepatitis, since active disease not only
impairs an individual’s military readiness, but also can threat-
en a large number of troops. Military personnel are consid-
ered to have a higher risk for hepatitis A than the civilian
population (8). However, there are no data available regard-
ing HAV infection in Korean military personnel. Thus, the
goal of this study was to determine the incidence rate and
the prevalence of antibody to hepatitis A in young soldiers in
the Republic of Korea (ROK) Army.
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Incidence and Seroprevalence of Hepatitis A Virus Infections among
Young Korean Soldiers
This study was performed to determine the incidence and seroprevalence of hep-
atitis A virus (HAV) infections in young soldiers in the Republic of Korea Army. From
January 2000 through December 2004, a total of 147 hepatitis A cases were report-
ed to the Armed Forces Medical Command. The annual incidence rates were 7.4
per 100,000 persons in 2000, 1.6 in 2001, 4.4 in 2002, 9.8 in 2003, and 6.2 in 2004,
based on the reported cases among approximately 500,000 soldiers. All patients
were males with a median age of 21 yr (range, 19-27). The most common symp-
tom was nausea (86.5%), and all patients had recovered without complications. In
addition, in order to evaluate the seroprevalence of HAV infection in young adults,
serum samples were obtained from randomly selected young subjects among those
who had been admitted to the Armed Forces Capital Hospital from September 2005
to February 2006. A total of 200 subjects were enrolled in the study to analyze the
anti-HAV immune status. The overall anti-HAV IgG seropositive rate was 2% (4/
200, 95% CI, 0.60-5.21%). Given the changing epidemiology of the disease and
the associated increase in morbidity, it was suggested that the routine HAV vacci-
nation for Korean military personnel might be necessary.
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MATERIALS AND METHODS
The database of the Armed Forces Medical Command
(Defense Medical Information System; DEMIS) was review-
ed to identify the number of hepatitis A cases reported. In
the ROK Army, it is mandatory to report individual cases
of communicable diseases, including viral hepatitis, to the
Department of Preventive Medicine in the Armed Forces
Medical Command (9). We analyzed the data of hepatitis A
cases that had been submitted from January 2000 to Decem-
ber 2004. The annual incidence rate was defined as cases per
100,000 persons per year among approximately 500,000
soldiers. The cases were defined as epidemic cases when more
than two cases had occurred in the same military unit with-
in a 4-week period. We retreived data from electronic medi-
cal records (DEMIS) and obtained baseline demographic and
clinical information, including age, gender, clinical symp-
toms, and laboratory findings.
In addition, we planned an additional study in order to
evaluate the seroprevalence of HAV infection. Serum sam-
ples were obtained from randomly selected subjects among
those who had been admitted to the Armed Forces Capital
Hospital from September 2005 to February 2006. Patients
who are over 25 yr old, chronic disease cases, viral hepatitis
cases, and females were excluded. We, therefore, planned to
obtain a specific study group that included healthy young
military personnel. Informed consent was obtained. Anti-
HAV IgG and anti-HBs IgG antibodies were measured by
AXSYM (Abbott Laboratories, Wiesbaden, Germany). The
test was performed in an automated format, and cut-off val-
ues were established according to the instructions by the
manufacturer.
RESULTS
A total of 147 cases of hepatitis A were reported in young
Korean soldiers from January 2000 through December 2004.
Of these, 64 (43.5%) cases were reported as epidemic cases,
and the remaining 83 (56.5%) were reported as sporadic cases
(Table 1). The mean annual incidence of hepatitis A was 5.9
per 100,000 persons, based on the cases reported among app-
roximately 500,000 soldiers. The annual incidence rates were
7.4 per 100,000 persons in 2000, 1.6 in 2001, 4.4 in 2002,
9.8 in 2003, and 6.2 in 2004. A total of 111 male patients
with acute hepatitis A were analyzed and their median age
was 21 yr old (range, 19 to 27 yr). The remaining 36 cases
were excluded from the analysis since the medical records
were unavailable. Table 2 shows clinical characteristics and
initial laboratory findings of patients with acute hepatitis A
in the military personnel of Korea. The most common symp-
tom was nausea (86.5%), and all patients had recovered with-
out complications.
A total of 200 subjects were enrolled in the study to ana-
lyze anti-HAV immune status. All patients were male with
a median age of 21 yr (range, 19-24). The overall anti-HAV
IgG seropositive rate was 2% (4/200, 95% CI, 0.60-5.21%).
The prevalence of anti-HBs IgG was detected as 72.9% (146/
200, 95% CI, 66.44-78.69%).
DISCUSSION
In this study of HAV infections among Korean soldiers,
the data suggested that the annual incidence of hepatitis A
was approximately 6 per 100,000 persons. The cases of hep-
atitis A reported have sustained steadily over the past 5 yr,
and 11 outbreaks in the military personnel have been report-
ed. An anti-HAV IgG seropositivity of 2% in our study was
lower than those reported in these age groups in other devel-
oping countries (2, 10).
In Korea, the incidence and seroprevalence of hepatitis A
in military personnel have not been previously available. Reli-
able epidemiological data are essential for the adequate con-
trol of viral hepatitis. It is necessary to know the exact num-
ber of new cases in order to place the prevalence of HAV infec-
tions in a proper perspective and establish a realistic control
program. To the best of our knowledge, this is the first study
2000 Year 2001 2002 2003 2004 Total
No. of reported cases 37 8 22 49 31 147
Incidence per 100,000  7.4 1.6 4.4 9.8 6.2 5.9
persons (Mean)
Outbreak 2 1 1 5 2 11
No. of epidemic cases  23 3 3 31 4 64
Table 1. Annual incidence of the hepatitis A cases reported am-
ong young Korean soldiers
*Values are reported as no. (%) of patients unless otherwise indicated.
� Values are reported as mean±standard deviation (range). 
� Peak biliru-
bin level (mg/dL); 7.2±4.6 (1.8-22.9).
Characteristics Value (n=111)
Age, median yr (range) 21 (19-27)
Symptoms*
Fever 72 (64.9%)
Nausea 96 (86.5%)
Jaundice 78 (70.3%)
Abdominal pain 33 (29.7%)
Laboratory findings
�
AST (IU/L) 1608±1940 (45-9659)
ALT (IU/L) 2295±1383 (176-6559)
Bilirubin (mg/dL)
� 5.3±3.4 (0.5-19.1)
Protein (g/dL) 6.4±0.69 (5.0-7.9)
Albumin (g/dL) 3.6±0.4 (2.8-4.7)
WBC (/ L) 5407±1698 (2300-9900)
Hb (g/dL) 14.7±1.39 (10.4-16.6)
Platelet (K/ L) 190±78 (23-374)
Table 2. Clinical characteristics and initial laboratory findings of
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on the extent of HAV infections among young soldiers in
ROK Army which has a draft system.
In the past, hepatitis A epidemics were mainly related to
the overcrowding and lack of hygienic sanitary conditions
typical for military life. In addition, most papers reporting
hepatitis A epidemics in the forces were published before
1990 (8). Almost all of the studies published thereafter dis-
cussed the efficacy of the vaccine and suggest different vac-
cination schedules for the militaries, taking it for granted
that they were a high-risk group and need prophylaxis (8).
Militaries are considered just as a sample of the general pop-
ulation in most papers, in which a decrease in seroprevalence
was generally found for all population groups in recent years.
In fact, a recent paper reported a hepatitis A incidence rate in
militaries similar to that found in the general population (11).
Now, due to the improvement of the sanitation level, the risk
is mainly ascribed to travels to high endemicity areas.
Among Korean civilians, the overall seropositivity rate of
HAV IgG in subjects under 20 yr of age was 63.8% in 1979
and 50.3% in 1989, followed by a rapid decline to 11.7% in
1995, and 4.6% in 1996 (3). The results of epidemiologic
studies including our data indicate that Korea is in transition
from a high- to low-endemicity region (3, 6). The seropreva-
lence of HAV infection in young Korean soldiers was approx-
imately 2%, comparable to that in low endemicity countries
(12).
The low rate of natural infection clearly indicates that a
large part of the younger population is susceptible to HAV
infection with the potential for large-scale outbreaks, unless
they acquire proper immunity. Food-born or water-born out-
breaks in susceptible people may become a problem in the
future. The strong evidence for the decreasing incidence of
HAV infection as a result of improved personal hygiene and
living conditions, supported by the economic growth, will
increase the risk of future outbreaks (8, 10).
Inactivated hepatitis A vaccine has been available since
1997 in Korea (3, 4). The vaccine is recommended for use
in people including children who are at increased risk of infec-
tion (3, 4). However, immunization with hepatitis A vaccine
is not recommended in healthy young adults as part of a rou-
tine immunization schedule. Since 1996, several outbreaks
of hepatitis A in young adults and school children have indi-
cated that there is a need for active immunization in adoles-
cents and young adults at increased risk, such as military per-
sonnel. As suggested by Sohn et al., Korea requires an evalu-
ation of the cost-effectiveness of implementing a routine sche-
dule of HAV immunization in children (3). The evaluation
of the cost-effectiveness of routine immunization of HAV in
Korean military personnel is also warranted. For Hepatitis
B immunization, a cost-effectiveness study was conducted by
military investigators, who concluded that screening for hep-
atitis B immunity was cost-effective when the prevalence of
immunity was >12% in new military recruits (13). When
considering HAV immunization for young Korean soldiers,
our data suggest that the routine screening for hepatitis A
immunity may not be cost-effective.
This study was based on the data of routine reportes and
medical records. Thus, the quality of the data may not be op-
timal. Patient with minor symptoms were not included in
the data if they did not seek medical attention or if they were
not reported.
In conclusion, we described a population-based study of
the epidemiology of HAV infections among the military per-
sonnel of Korea, and the overall HAV seroprevalence was ap-
proximately 2%. Given the changing epidemiology of the
disease and the associated increase in morbidity, it is suggest-
ed that the routine HAV vaccination of Korean military per-
sonnel might be mandatory.
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